Cargando…
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
BACKGROUND: Extrapulmonary small cell carcinomas (ESCC) are rare but aggressive tumors. Relapses are common despite treatment with chemotherapy and/or radiotherapy. Prospective data for treatment of ESCC are lacking; treatment of these cancers usually incorporates lung small cell carcinoma treatment...
Autores principales: | Salhab, Mohammed, Migdady, Yazan, Donahue, Melanie, Xiong, Yiqin, Dresser, Karen, Walsh, William, Chen, Benjamin J., Liebmann, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975459/ https://www.ncbi.nlm.nih.gov/pubmed/29843803 http://dx.doi.org/10.1186/s40425-018-0359-1 |
Ejemplares similares
-
Extrapulmonary Small Cell Carcinoma of the Liver: Clinicopathological and Immunohistochemical Findings
por: Choi, Suk Jin, et al.
Publicado: (2007) -
Paroxysmal Nocturnal Hemoglobinuria Presenting with a Left Intraventricular Thrombus in a Patient with Prior Thymoma and Aplastic Anemia
por: Migdady, Yazan, et al.
Publicado: (2011) -
Prognostic Value of PD-L1 Immunohistochemical Marker in Gastric Carcinoma and Its Correlation with HER2 Status
por: Attia, Samar, et al.
Publicado: (2022) -
Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
por: Müller, W., et al.
Publicado: (1996) -
Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer
por: Taha, Anas, et al.
Publicado: (2022)